Discover the full record of transactions filed by Jérôme Cerisier, Chief Executive Officer of EXOSENS. Officer active across 1 companies, notably EXOSENS. Aggregated, 2 reports have been logged. Total volume traded: €6.5m. The latest transaction was disclosed on 4 June 2025 — Cession. Regulator: AMF. The full history is accessible without signup.
2 of 2 declarations
Jérôme Cerisier is the Chief Executive Officer of EXOSENS, a role he has held since September 2016, after briefly serving as Deputy Chief Executive Officer. In this position, he leads the strategy and execution of a high-technology group specializing in advanced light amplification, detection, and imaging technologies for defense, life sciences, nuclear, and industrial control markets. Since Exosens was listed on Euronext Paris on June 7, 2024, he has overseen the company’s next phase of growth, with a focus on innovation, international expansion, and long-term value creation. Before joining Exosens, Cerisier built a career spanning industrial operations, strategic consulting, and engineering leadership. Exosens states that he held several management positions at Zodiac Aerospace from 2006 to 2013. It also notes that he served as Head of Purchasing and Performance Improvement for Aerazur’s Elastomer Technologies and Systems business, and later became General Manager of that activity before joining the Exosens group. Earlier in his career, he worked as an engineer at the Direction Générale de l’Armement, France’s defense procurement agency, and then at A.T. Kearney, where he was responsible for operations and strategy assignments across several countries. He is a graduate of École Polytechnique, ISAE-Supaéro, and INSEAD, combining technical depth with executive management training. As CEO, Cerisier has helped steer Exosens through a period of transformation and expansion. The company highlights acquisitions such as Xenics, ProxiVision, Telops, and El-Mul as key steps in broadening its technological portfolio and strengthening its position in demanding, fast-growing imaging and detection markets. He also emphasizes the group’s industrial footprint, patent base, and presence in more than 50 countries, as well as its mission to deliver reliable technologies in critical environments. In addition to supporting organic and external growth, he has advanced Exosens’ CSR agenda and promoted employee share ownership through ExoShare, reinforcing internal engagement and alignment with the company’s strategy.